Work

Primary data analyses of MAESTRO-NAFLD-1 a 52 week double-blind placebo-controlled phase 3 clinical trial of resmetirom in patients with NAFLD

Year: 2022

Type: article

Source: Journal of Hepatology

DOI: 10.1016/s0168-8278(22)00445-7

Authors: Stephen Harrison, Rebecca Taub, Guy Neff, Sam Moussa, Naim Alkhouri, Mustafa Bashir

Institutions: Pinnacle Clinical Research, Madrigal Pharmaceuticals (United States), Covenant Research and Clinics (United States), Adobe Gastroenterology, Duke University

Language: English

Topic: Liver Disease Diagnosis and Treatment

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4283818167

FWCI: 2.356

Cites:

Cited by: 13

Related to: 10